Current challenges for cancer vaccine adjuvant development
Introduction: Although much progress has been made in the last decade(s) toward development of effective cancer vaccines, there are still important obstacles to therapeutic successes. New generations of cancer vaccines will benefit from a combination adjuvant approach that targets multiple branches...
Saved in:
Main Authors: | William S. Bowen (Author), Abhishek K. Svrivastava (Author), Lalit Batra (Author), Hampartsoum Barsoumian (Author), Haval Shirwan (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants
by: Sumin Han, et al.
Published: (2023) -
Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities
by: Diego A. Díaz-Dinamarca, et al.
Published: (2022) -
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
by: Arnaud M. Didierlaurent, et al.
Published: (2017) -
Using PAMPs and DAMPs as adjuvants in cancer vaccines
by: Huanyou Sun, et al.
Published: (2021) -
Promising Adjuvants and Platforms for Influenza Vaccine Development
by: Wandi Zhu, et al.
Published: (2021)